Table 3.
Comparison of laboratory data at the start (day 0) and the end of treatment (day 18).
| Day | Oral iron (n = 9) | EPO + oral iron (n = 10) | EPO + IV iron (n = 10) | ANOVA p value | |
|---|---|---|---|---|---|
| sTfR, mg/l | 0 | 2.32±0.41 | 2.19±0.35 | 1.76±0.13 | NS |
| 18 | 2.59±0.57 | 5.57±0.53 | 6.69±0.71 | <0.01a | |
| Ferritin, μg/l | 0 | 309.8±32.1 | 380.9±72.3 | 352.4±55.4 | NS |
| 18 | 171.2±35.6 | 233.1±43.0 | 852.1± 167.5 | <0.01 b, c | |
| Ferritin index | 0 | 0.95±0.17 | 0.89±0.16 | 0.71±0.06 | NS |
| 18 | 1.21±0.27 | 2.50±0.32 | 2.34±0.24 | <0.05a | |
| CHr, pg | 0 | 27.6±0.5 | 28.0±0.6 | 28.6±0.8 | NS |
| 18 | 26.6±0.3 | 28.8±0.6 | 27.5±0.4 | <0.05d | |
| Hb, g/l | 0 | 112±3 | 117±8 | 115±5 | NS |
| 18 | 92±3 | 102±7 | 113±6 | <0.05a |
Values shown are mean±SEM. NS = Not significant.
a
EPO + IV iron group and EPO + oral iron group compared with the oral iron group.
b
EPO + IV iron group compared with the oral iron group.
c
EPO + IV iron group compared with EPO + oral iron group.
d
EPO + oral iron group compared with the oral iron group.